Viewing StudyNCT00070291



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00070291
Status: TERMINATED
Last Update Posted: 2023-06-29
First Post: 2003-10-03

Brief Title: Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01-24
Start Date Type: ACTUAL
Primary Completion Date: 2009-03
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05
Completion Date Type: ACTUAL
First Submit Date: 2003-10-03
First Submit QC Date: October 6 2003
Study First Post Date: 2003-10-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-02-08
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-14
Last Update Post Date: 2023-06-29
Last Update Post Date Type: ACTUAL